Table 4. cART effectiveness and CD4 change models at 6, 12, and 24 months for premenopausal and postmenopausal antiretroviral-naïve women.

	6 months	12 months	24 months
All patients	N = 230	N = 228	N = 210
cART effectiveness [OR (95%CI)]	1.00 (0.86–1.17)	1.02 (0.87–1.19)	1.02 (0.85–1.22)
	N = 213	N = 222	N = 207
CD4 Change coefficients (Standard error)	−7.6(29.0)	−27.4(31.2)	−97.8(39.9)
	N = 213	N = 222	N = 207
>25% CD4 cell count increase [OR(95%CI)]	1.06 (0.43–2.59)	0.69 (0.29–1.69)	0.46 (0.17–1.26)
In patients with viral load ≤400 copies/mL	N = 164	N = 167	N = 166
CD4 Change coefficients (Standard error)	−14.3(34.8)	−35.4(35.9)	−61.1(44.4)
	N = 164	N = 167	N = 166
>25% CD4 cell count increase [OR(95%CI)]	0.69 (0.24–1.95)	0.38 (0.14–1.07)	0.46 (0.11–1.92)

cART: Combination Antiretroviral Therapy; OR: Odds Ratio.

Models adjusted for baseline log 10 HIV-1 RNA levels, baseline CD4, HAART regimen and AIDS defining illness.

p<0.05 in bold.